Cybin inc. reports second quarter financial results and recent business highlights

Toronto--( business wire )--cybin inc. (neo:cybn) (nyse american:cybn) (“cybin” or the “company”), a biopharmaceutical company focused on progressing psychedelics to therapeutics®, today reported unaudited financial results for its second quarter ended september 30, 2022, and recent business highlights.

CYBN Ratings Summary

CYBN Quant Ranking